The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger than 8 months receiving clesrovimab (Enflonsia) to prevent respiratory ...

The CDC's Advisory Committee on Immunization Practices voted to ban thimerosal, a harmless preservative, in what critics say ...

We cannot and will not gamble with our patients’ health or the health of our communities,” write the presidents of the AAFP, ...

A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new preventive shot against ...

Smartwatches may detect illness before symptoms begin, helping users isolate early and slow the spread of diseases like COVID ...

Health experts have warned families across Toowoomba and the southwest to be vaccine vigilant as whooping cough cases spike ...

As winter viruses surge across Australia, thousands of patients are turning to fast, affordable online doctors to avoid long waits and overwhelmed ...

In the wake of this week's meeting of a newly reconstituted federal vaccine advisory board, public health, medical, and ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...

The CDC's vaccine advisory committee voted on Thursday to recommend infants receive a newer monoclonal antibody shot for ...

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

RAHWAY, N.J., June 09, 2025--U.S. FDA Approves Merck’s ENFLONSIA for Prevention of RSV Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season ...